Evidence map›Paper›PMID 33490721›Full record

ArticleAdvances in radiation oncology

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases.

Matthew Chan, David Palma, Aisling Barry, Andrew Hope, Richard Moore, Melissa O'Neil, Janet Papadakos, Devin Schellenberg, Tony Tadic, C Jillian Tsai and 1 more

Open access · goldAbstract read
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Matthew ChanRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
David PalmaDivison of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada.
Aisling BarryRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Andrew HopeRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Richard MooreRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Melissa O'NeilDepartment of Radiation Therapy, London Health Sciences Centre, London, Ontario, Canada.
Janet PapadakosDepartment of Cancer Education, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Devin SchellenbergDepartment of Radiation Oncology, BC Cancer - Surrey Centre, Surrey, British Columbia, Canada.
Tony TadicRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
C Jillian TsaiDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, New York.
Meredith GiulianiRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre · CALondon Health Sciences Centre · CAUniversity of Toronto · CAMemorial Sloan Kettering Cancer Center · USSurrey Place Centre · CA

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeWith multiple phase 2 trials supporting the use of stereotactic body radiation therapy (SBRT) in oligo-metastatic disease, we evaluated practices that could inform effective implementation of an oligo-metastasis SBRT program. METHODS AND MATERIALS: Using a context-focused realist methodology, an advisory committee of interprofessional clinicians met over a series of semistructured teleconference meetings to identify challenges in implementing an oligo-metastasis SBRT program. Consideration was given to 2 models of care: a subspecialist anatomic expertise model versus a single-practitioner "quarterback" model.

resultsThe advisory committee structured recommendations within a context-mechanism-outcome framework. In summary, the committee recommends that during patient workup, a single practitioner arranges the minimum number of necessary tests, with case presentation at an appropriate multidisciplinary tumor board, including careful review of all previous treatments, and enrollment on clinical trials when possible. At simulation, common patient positions and immobilization on a single simulation scan for multiple sites is recommended. During radiation planning, dose-fractionation regimens should safely facilitate cumulative dose calculations, a single isocenter should be considered for multiple close targets to reduce treatment time, and adherence to strict quality assurance protocols is strongly recommended. Treatment duration should be minimized by treating multiple sites on the same day or choosing shorter dose fractionations. Team communication, thorough documentation, and standardized nomenclature can reduce system errors. Follow-up should aim to minimize redundant clinical appointments and imaging scans. Expert radiology review may be required to interpret post-SBRT imaging.

conclusionsThese guidelines inform best clinical practices for implementing an oligo-metastasis SBRT program. Iterations using a realist approach may further expand on local contexts.

Identifiers

PMID33490721
PMCPMC7811116
OpenAlexW3036181203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.